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ABSTRACT
Human GCMa transcription factor regulates
expression of syncytin, a placental fusogenic protein
mediating trophoblastic fusion. Recently, we have
demonstrated that CBP-mediated GCMa acetylation
underlies the activated cAMP/PKA signaling pathway
thatstimulatestrophoblasticfusion.Becauseprotein
acetylation is a reversible modification governed
by histone acetyltransferases (HATs) and histone
deacetylase (HDACs), in this study we investigated
the key HDACs responsible for deacetylation of
GCMa and thus the reduction in GCMa activity to
avoid unwanted fusion events that may have adverse
effects on placental morphogenesis. We herein
demonstrate that the HDAC inhibitor, trichostatin A
(TSA), increases the level of acetylated GCMa and
that HDAC1, 3, 4 and 5 interact with and deacetylate
GCMa. Glutathione S-transferase (GST) pull-down
assays further verified direct interaction between
GCMa and HDAC3 or CBP and HDAC3. HDAC3 coun-
teracts the transcriptional coactivator activity of
CBP and the enhancement effect of CBP on GCMa-
mediated transcriptional activation. Correlatively,
we found in placental cells that HDAC3 associates
with the proximal GCMa-binding site (pGBS) in the
syncytin promoter and dissociates from pGBS in
the presence of forskolin, which stimulates the asso-
ciation of CBP and GCMa with pGBS. Our studies
support that trophoblastic fusion in placental
morphogenesis depends on the regulation of GCMa
activity by HAT and HDAC.
INTRODUCTION
The GCM (Glial Cell Missing) transcription factors, GCMa/1
and GCMb/2, form a novel family of transcription factors with
a characteristic zinc-containing DNA-binding domain (termed
GCM motif) in their N-termini. GCM transcription factors
play important roles in development. Drosophila GCM1 regu-
lates the differentiation of glial cells from neuronal precursor
cells, whereas murine GCMa and b regulate the formation of
the placental syncytiotrophoblasts and parathyroid gland,
respectively (1–6). Recently, zebraﬁsh GCMb has been char-
acterized and shown to be required for pharyngeal cartilage
formation (7,8). Identiﬁcation of target genes and associated
factors of GCM transcription factors has shed new light on the
molecular mechanisms underlying the above-mentioned
developmental outcomes. For instance, Drosophila GCM1
regulates expression of repo (reverse polarity) and pnt
(pointed) genes, which are two principal mediators of glial
differentiation, whereas human GCMa regulates expression of
syncytin gene, which encodes a placental fusogenic membrane
protein facilitating trophoblastic fusion (9,10). Interestingly,
Drosophila GCM1 can positively regulate its own expression
via ﬁve GCM-binding sites in its promoter region (11). More
recently, we have demonstrated that CBP directly interacts
with and acetylates GCMa in the activated cAMP/PKA sig-
naling pathway (12). In addition, Schubert et al. (13) have
identiﬁed Pitx2, a paired-like homeodomain transcription
factor, as a GCMa-interacting protein in a yeast two-hybrid
screen. Synergistic transcriptional activation mediated by
GCMa and Pitx2 has in fact been demonstrated in placental
cells (13). In terms of protein turnover, GCMa can be targeted
to the ubiquitin–proteasome degradation system by the F-box
protein, FBW2 (14). Therefore, regulation of GCMa/1 activity
during development can be achieved by post-translation modi-
ﬁcation, protein–protein interaction and autoregulation.
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doi:10.1093/nar/gkl048Protein acetylation at the e-amino group of lysine residue is
a reversible and dynamic post-translational modiﬁcation that
regulates a variety of protein functions involved in chromatin
assembly, protein–protein interaction, stability, DNA-binding
activity, transcriptional activity and nuclear localization, to
name but a few. The acetylation status of protein substrates
is regulated by histone acetyltransferases (HATs) and histone
deacetylase (HDACs). HATs catalyze the transfer of acetyl
groups from acetyl-CoA to the e-amino groups of lysine
residues in proteins and play an important role in the regula-
tion of transcriptional machinery and gene expression. For
instance, CBP is a transcription coactivator connecting differ-
ent transcription factors to the transcription machinery or
providing a scaffold to form a multicomponent transcriptional
regulatory complex (15). In addition, CBP has an intrinsic
HAT activity to acetylate nucleosomal histones resulting in
changes in chromatin structure and non-histone proteins
affecting their biological activities (15). HDACs reverse the
enzyme reaction catalyzed by HATs and promote transcrip-
tional repression. Mammalian HDACs are categorized into
three classes: class I RPD3-like HDACs (HDAC1, 2, 3 and
8) localize to the nucleus; class II HDA1-like HDACs (4, 5, 6,
7, 9 and 10) localize to both nucleus and cytoplasm; and class
III SIR2-like HDACs (SIRT1-7) are structurally distinct from
class I and II HDACs and require the cofactor NAD for their
enzymatic activities (16).
Cell–cell fusion is essential for formation of the multi-
nucleated syncytiotrophoblast layer during human placental
development. Recently, we have demonstrated that GCMa
is able to control placental cell fusion by upregulating syncytin
geneexpression (10).Moreover, wehave furtherdemonstrated
that CBP is involved in the stimulation of GCMa activity via
the cAMP/PKA signaling pathway (12). We have shown
that CBP enhances GCMa-mediated transcriptional activation
by acting as a transcriptional coactivator and as a HAT
acetylating GCMa to prolong its protein stability (12).
Therefore, the acetylation status of GCMa plays an important
role in the regulation of GCMa activity. In this study we
investigated the key HDACs that mediate deacetylation of
GCMa. We demonstrated that HDAC1, 3, 4 and 5 are able
to interact with and deacetylate GCMa. Moreover, we found
that CBP speciﬁcally interacts with HDAC1 and 3. Because
the interaction between CBP and HDAC3 is a new ﬁnding and
may further complicate current understanding of how GCMa
activity is regulated, we characterized the interaction between
GCMa, HDAC3 and CBP and studied the regulation of
GCMa-mediated transcriptional activation by HDAC3. Our
study identiﬁed HDAC3 as a key factor reversing GCMa
acetylation and suggests that HDAC3 can functionally
attenuate the CBP-upregulated GCMa activity in the activated
signaling pathway leading to placental cell fusion.
MATERIALS AND METHODS
Plasmid constructs
The expression plasmids pHA-GCMa, pPKAcata, pCBP-HA,
pCBP-Flag,pCBP
HAT-HAandpGal4-GCMa-Flaghave been
described previously (12). The pGCMa-Flag expression
plasmid was constructed by cloning into the pEF1-MycHis
(Invitrogen, Carlsbad, CA), a DNA fragment encoding
human GCMa with a C-terminal triple FLAG tag. The
HDAC expression plasmids pHDAC1-, 2-, 3-, 4- and
5-Myc or -Flag were constructed by placing the respective
ORF cDNA with a C-terminal four copies of Myc tag or
a C-terminal one copy of FLAG tag under the control
of cytomegalovirus (CMV) early promoter/enhancer. The
reporter constructs, p(pGBS)4E1bLUC and pLUC(25468–
30953), have been described previously (12). All constructs
were veriﬁed by DNA sequencing using the dideoxy chain-
termination method.
Cell culture, transfection and reporter gene assay
293T cells were obtained from the American Type Culture
Collection (ATCC) (Manassas, VA) and maintained at 37C
in HEPES-buffered DMEM supplemented with 10% FBS,
streptomycin (100 mg/ml) and penicillin (100 U/ml). The
human trophoblast cell lines, JEG3, BeWo and JAR, was
obtained from ATCC and maintained at 37C in F-12K
medium supplemented with 15% FBS, streptomycin
(100 mg/ml) and penicillin (100 U/ml). For transient expres-
sion experiments, cells were transfected with the indicated
amounts of reporter plasmid and expression plasmid as
described in ﬁgure legends using the TransIT LT1 reagent
(Mirus, Madison, WI). In addition, adjusted amounts of the
empty expression vector were added to maintain a constant
amount of total DNA in each transfection assay. For luciferase
reporterassays,cellswere harvested inthe reporter lysisbuffer
(Promega, Madison, WI) 48 h post-transfection and analyzed
as described previously (12). Speciﬁc luciferase activities
were normalized by protein concentration. Protein concentra-
tions were measured using the BCA protein assay kit (Pierce,
Rockford, IL).
In vivo acetylation/deacetylation analysis
To study the effect of trichostatin A (TSA) on GCMa
acetylation in vivo, 293T cells were transfected with different
combinations of pGal4-Flag, pGal4-GCMa-Flag, pCBP-HA
and pPKAcata. After 24 h post-transfection, cells were
mock-treated or treated with the indicated amount of TSA
for an additional 18 h. Cells were then harvested in the
lysis buffer A containing 20 mM HEPES (pH 8.0),
100 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.05%
Tween-20, 5% glycerol, 1 mM Na3VO4, 5 mM NaF and
1 mM phenylmethlysulfonyl ﬂuoride (PMSF) for immuno-
precipitation with a guinea pig anti-GCMa polyclonal anti-
body (GCMa Ab). The immune complexes were further
analyzed by immunoblotting with a mouse anti-acetylated-
lysine monoclonal antibody (Ac-K mAb, Cell Signaling,
Beverly, MA). To identify the HDAC responsible for
deacetylation of GCMa, 293T cells were transfected with
different combinations of pGal4-Flag, pGal4-GCMa-Flag,
pCBP-HA, pPKAcata and pHDAC1-5-Myc. After 48 h
post-transfection, cells were harvested for acetylation analysis
as described above.
Co-immunoprecipitation
To study the interaction between GCMa and HDAC,
293T cells were cotransfected with pHA-GCMa and
pHDAC1-, 2-, 3-, 4- or 5-Myc as described in the legend of
Figure2A.After48 hpost-transfection, cells were harvestedin
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monoclonal antibody (HA mAb, Sigma, St Louis, MO). The
immune complexes were further analyzed by immunoblotting
with the 9E10 Myc mAb (Roche, Mannheim, Germany).
A reciprocal experiment was performed by immunoprecipita-
tion of the cell lysate with Myc mAb, followed by immuno-
blotting with HA mAb. To study the interaction between
CBP and HDAC, 293T cells were cotransfected with
pCBP-HA and pHDAC1-, 2-, 3-, 4- or 5-Myc as described
in the legend of Figure 3A. Co-immunoprecipitation was
performed as in the aforementioned procedures. Characteriza-
tion of the interaction between HDAC3, GCMa and CBP
was performed by transfecting 293T cells with pHDAC3-
Myc, pGCMa-Flag and pCBP-HA, followed by co-
immunoprecipitation using the indicated combinations of
HA and Myc mAbs and a mouse anti-FLAG monoclonal anti-
body (FLAG mAb, Sigma). To study the effect of HDAC3 on
GCMa protein stability, 293T cells were transfected with
different combinations of pHA-GCMa, pCBP-Flag and
pHDAC3-Myc, followed by pulse-chase analysis as described
previously (12).
Sedimentation analysis
293T cells were transfected with pCBP-Flag, pHA-GCMa and
pHDAC3-Myc. After 48 h post-transfection, cells were
harvested and the CBP–Flag complexes were immunopreci-
pitated using the above-mentioned procedures, followed by
elution using 200 mg/ml of FLAG peptide. For sedimentation
analysis, the eluted CBP–Flag complexes were analyzed in a
10 to 30% glycerol gradient in phosphate-buffered saline
(PBS) in an SW40 Ti rotor (Beckman Coulter, Fullerton,
CA) at 35000 r.p.m. (150000 · g) for 40 h. A total of 16 frac-
tions were collected from the bottom of centrifuge tube and
analyzed by immunoblotting using HA, FLAG and Myc
mAbs, respectively.
Glutathione S-transferase (GST) pull-down assay and
interaction domain mapping
The GST fusion protein expression vector pGEX6P-1
(Amersham Biosciences, Piscataway, NJ) was used for
preparation of the GST–HDAC3 fusion protein in Escherichia
coli strain BL21(DE3). Puriﬁcation of GST fusion proteins
was performed as described by Frangioni and Neel (17).
Recombinant GCMa-Flag and Flag-CBP proteins were
prepared by the baculovirus-insect cell expression system as
described previously (10,12). To study the physical interaction
between GCMa and HDAC3, GST pull-down experiments
were performed by incubating 0.4 mg of GCMa-Flag and
2.5 mg of GST or GST-HDAC3 pre-bound to glutathione
beads (Amersham Biosciences) in lysis buffer A at 4C for
4 h. The beads were then washed ﬁve times with lysis buffer A
and analyzed by immunoblotting with FLAG mAb. Similar
experiments were performed to study the physical interaction
between CBP and HDAC3.
Tomap theinteractiondomain ofGCMa forHDAC3,MBP-
HDAC3 or MBP was incubated with GST or a series of GST
fusion proteins of full-length or deletion GCMa as indicated in
Figure 4B in lysis buffer A at 4C overnight. To map the
interaction domain of CBP for HDAC3, MBP-HDAC3 or
MBP was incubated with GST or a series of GST fusion
proteins of deletion CBP as indicated in Figure 4B in lysis
buffer A at 4C for 4 h. MBP-GCMa and GST fusion proteins
were prepared as described previously (12). Preparation of
MBP-HDAC3 was similar to that of MBP-GCMa. After
incubation, the beads were washed ﬁve times with lysis buffer
A and analyzed by immunoblotting with a mouse anti-MBP
monoclonal antibody (MBP mAb, Clontech, Palo Alto, CA).
Chromatin immunoprecipitation (ChIP) assay
Approximately3 · 10
6BeWocells were mock-treatedortrea-
ted with 50 mM forskolin for 24 h or 50 ng/ml of TSA for 12 h
before being subjected to a ChIP assay as described previously
(12). Associated protein–DNA complex were incubated with
HDAC3 (Abcam, Cambridge, UK) or Ac-H3 (recognizing
acetylayed-K9 and -K14, Upstate, Lake Placid, NY) antibody
and then precipitated with protein A-conjugated agarose
beads. PCR conditions and primer sequences for a speciﬁc
region containing the pGBS sequence in the syncytinpromoter
and for a speciﬁc region in the GAPDH promoter have been
described previously (12).
RESULTS
TSA increases the transcriptional activity of GCMa
Recently we have demonstrated that activation of the cAMP/
PKA signaling pathway by forskolin leads to CBP-dependent
acetylation of GCMa, which stabilizes GCMa and enhances
GCMa-mediated transcriptional activation (12). Increased
GCMa activity can promote trophoblastic fusion events in
cultured placental BeWo cells and may have a similar effect
during placental development. Because protein acetylation is a
reversible modiﬁcation, we investigated whether HDACs are
involved in the deacetylation of GCMa and thereby the regu-
lation of GCMa activity. To this end, we tested the effect of
TSA, a class I and II HDAC inhibitor, on the level of
acetylated GCMa in 293T cells transfected with pGal4-
GCMa-Flag, pCBP-HA and pPKAcata. As shown in
Figure 1A, CBP-mediated acetylation of Gal4-GCMa-Flag
was speciﬁcally detected because Gal4-Flag was not acet-
ylated in the presence of CBP and Gal4-GCMa-Flag was
not acetylated in the absence of CBP. Moreover, the level
of acetylated Gal4-GCMa-Flag was further increased by
TSA in a dose-dependent manner. We also tested the effect
of nicotinamide, a class III HDAC inhibitor, in a similar
experiment and did not detect any signiﬁcant effect on the
level of acetylated GCMa (data not shown). These results
suggested that deacetylation of GCMa is very likely to be
regulated by class I or II HDACs in vivo.
We further investigated the effect of TSA on GCMa
transcriptional activity. 293T cells were transfected with
different combinations of p(pGBS)4E1bLUC, pHA-GCMa,
pCBP-HA and pPKAcata, followed by treatment with or
without TSA. As shown in Figure 1B, the luciferase activity
directed by p(pGBS)4E1bLUC was stimulated by GCMa,
which could be enhanced by PKA or to a higher degree by
a combination of PKA and CBP. Interestingly, the positive
effect of PKA alone or PKA and CBP on GCMa transcrip-
tional activity was further stimulated by TSA (Figure 1B).
Moreover, the stimulation of GCMa transcriptional activity
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GCMa alone or together with PKA and CBP (Figure 1C).
These results suggested that inhibition of GCMa deacetylation
enhances the transcriptional activity of GCMa.
Identification of HDACs interacting with and
deacetylating GCMa and CBP
To identify HDACs involved in GCMa deacetylation, we
investigated the protein–protein interaction between GCMa
and HDAC1-5 by co-immunoprecipitation. 293T cells were
transfected with pHA-GCMa and the indicated pHDAC1-, 2-,
3-, 4- or 5-Myc expression plasmid. After immunoprecipita-
tion of GCMa with HA mAb and immunoblotting with Myc
mAb, speciﬁc interactions were detected between GCMa and
HDAC1, 3, 4 and 5 (Figure 2A). Correspondingly, the same
result was observed in a similar experiment by immunoprecip-
itation of HDACs with Myc mAb and immunoblotting with
HA mAb (Figure 2A). Therefore, GCMa interacts with
HDAC1, 3, 4 and 5, but not HDAC2. As a complementary
approach, we also identiﬁed the HDACs that catalyze
deacetylation of GCMa in 293T cells transfected with
pGal4-GCMa-Flag, pCBP-HA, pPKAcata and pHDAC1-,
2-, 3-, 4- or 5-Myc. As shown in Figure 2B, the level of
acetylated Gal4-GCMa-Flag was signiﬁcantly reduced by
HDAC1, 3, 4 and 5, but not HDAC 2. Taken together,
these results suggested that HDAC1, 3, 4 and 5 interact
with and deacetylate GCMa in vivo.
Figure1.RegulationofGCMaactivitybyTSA.(A)TSAincreasesthelevelofacetylatedGCMa.293Tcellsweretransfectedwiththeindicatedcombinationsof2mg
of pGal4-Flag, 2 mg of pGal4-GCMa-Flag, 0.1 mg of pPKAcata and 1 mg of pCBP-HA. After 24 h post-transfection, cells were mock-treated or treated with an
increasing amount of TSA for another 24 h. The level of acetylated Gal4-GCMa-Flag was analyzed by immunoprecipitation using GCMa Ab and immunoblotting
using Ac-K mAb, as described in Materials and Methods. The protein level of Gal4-GCMa-Flag in each transfection group was detected by immunoblotting using
FLAGmAb.(BandC)TSA stimulatesGCMa-mediatedtranscriptionalactivation.293Tcellsweretransfectedwith0.6mgofp(pGBS)4E1bLUCplustheindicated
combinationsof0.5mgofpHA-GCMa,0.1mgofpPKAcataand0.5mgofpCBP-HA.After24hpost-transfection,cellsweremock-treatedortreatedwith100ng/ml
ofTSA(B)orincreasingamountsofTSA(C)foranother24h.Notethatadose-dependenteffectofTSAonGCMa-mediatedtranscriptionalactivationwasobserved.
Mean values and SEM obtained from three independent transfection experiments are provided.
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HAT (18), we investigated whether HDACs can also interact
with CBP. We analyzed the interaction between CBP and
HDAC1-5 by co-immunoprecipitation in 293T cells trans-
fected with pCBP-HA and pHDAC1-, 2-, 3-, 4- or 5-Myc.
As shown in Figure 3A, speciﬁc interactions between CBP
and HDAC1 and 3, but not HDAC2, 4 and 5, were detected
from using HA mAb for immunoprecipitation and Myc mAb
for immunoblotting. These results were also conﬁrmed in a
similar experiment using Myc mAb for immunoprecipitation
and HA mAb for immunoblotting (Figure 3A). Since the inter-
action between CBP and HDAC3 is a new ﬁnding and may
further complicate current understanding of how GCMa
activity is regulated, we focused on the roles of HDAC3 in
the regulation of CBP-mediated GCMa acetylation for the rest
of this study. To examine the interaction patterns between
CBP, GCMa and HDAC3 in vivo, we cotransfected 293T
cells with pGCMa-Flag, pCBP-HA and pHDAC3-Myc,
followed by co-immunoprecipitation using different pairs of
FLAG, Myc and HA mAbs as well as normal mouse serum
(NS) as a control. As shown in Figure 3B, speciﬁc interactions
were detected betweenGCMa and CBP, CBP and HDAC3 and
GCMa and HDAC3 using different combinations of FLAG,
Myc and HA mAbs, but not NS. We further characterized the
aforementioned interaction patterns by sedimentation analysis
of immunopuriﬁed and eluted CBP–Flag complexes from
293T cells transfected with pHA-GCMa, pCBP-Flag and
pHDAC3-Myc. The interaction between HA-GCMa and
CBP-Flag was instable after the elution of CBP-Flag (data
not shown). Nevertheless, the interaction between HDAC3-
MycandCBP-FlagandbetweenHDAC3-MycandHA-GCMa
is relatively stable for further sedimentation analysis. As
shown in Figure 3C, the HDAC3–CBP complex and the
HDAC3–GCMa complex were detected and located in differ-
ent fractions (fractions 4 and 5 for the HDAC3–CBP complex
and fractions 10, 11 and 12 for the HDAC3–GCMa complex),
suggesting that HDAC3 may differentially interact with CBP
and GCMa. Although signals for HA-GCMa and HDAC3-
Myc were detected in fractions 1 and 16 (Figure 3C), these
were likely due to protein aggregation and dissociation of
protein complex, respectively.
Identification of the interaction domains of GCMa and
CBP for HDAC3
We next performed GST pull-down experiments to verify the
direct interaction between GCMa and HDAC3 by incubating
recombinant GCMa-Flag protein with recombinant GST
or GST-HDAC3 protein. A similar experiment was also
performed to verify the direct interaction between CBP and
Figure 2. Identification of HDAC interacting with and deacetylating GCMa. (A) GCMa interacts with HDAC1, 3, 4 and 5. 293T cells were transfected with the
indicatedcombinationsof1mg ofpHA-GCMa,1.5 mgofpHDAC1-,3- and5-Myc,2 mgof pHDAC2-Myc and1mgofpHDAC4-Myc.After48 hpost-transfection,
cells were harvested for interaction analysis by co-immunoprecipitation as described in Materials and Methods. Note that results of reciprocal
co-immunoprecipitation experiments are presented (upper two panels). The protein levels of HA-GCMa and HDAC-Myc in the whole cell lysate (WCL) are
presented(lowertwopanels).(B)GCMaisdeacetylatedbyHDAC1,3,4and5.293Tcellsweretransfectedwiththeindicatedcombinationsof1mgofpGal4-GCMa-
Flag,0.1mgofpPKAcata,0.5mgofpCBP-HA,0.75mgofpHDAC1-,3-and5-Myc,1mgofpHDAC2-Mycand0.5mgofpHDAC4-Myc.After48hpost-transfection,
cells were harvested for immunoprecipitation using GCMa Ab and immunoblotting using Ac-K mAb as described in Materials and Methods. The protein levelo f
immnuopurifiedGal4-GCMa-FlagineachtransfectiongroupwasdetectedbyimmunoblottingusingFLAGmAb(middlepanel).TheproteinlevelsofHDAC-Myc
in the WCL are presented (lower panel). IP, immunoprecipitation. IB, immunoblotting.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1463Figure3.CharacterizationoftheinteractionbetweenHDAC3,GCMaandCBP.(A)CBPinteractswithHDAC1and3.293Tcellsweretransfectedwiththeindicated
combinations of 1 mg of pCBP-HA, 1.5 mg of pHDAC1-, 3- and 5-Myc, 2 mg of pHDAC2-Myc and 1 mg of pHDAC4-Myc. After 48 h post-transfection, cells were
harvested for interaction analysis by co-immunoprecipitation as described in Materials and Methods. Note that results of reciprocal co-immunoprecipitation
experimentsarepresented(uppertwopanels).TheproteinlevelsofCBP-HAandHDAC-MycintheWCLarepresented(lowertwopanels).(BandC)Analysisofthe
interaction between CBP, GCMa and HDAC3 by co-immunoprecipitation and sedimentation analysis. (B) 293T cells were transfected with 2 mg of pGCMa-Flag,
2.5 mgof pCBP-HA and1.5 mg ofpHDAC3-Myc.After48 h post-transfection,cells were harvested forco-immunoprecipitationusing the indicated combinationof
antibodiestodetectthelevelofimmunopurifiedproteinandtheinteractionbetweentheimmunopurifiedproteinandtheothertwoco-expressingproteins.NS,normal
serum.(C)293Tcellsweretransfectedwith2mgofpHA-GCMa,2mgofpCBP-Flagand2mgofpHDAC3-MycandtheCBP–Flagcomplexeswereimmunopurified,
elutedwithFLAGpeptide,andsubjectto10to 30%glycerolgradientcentrifugation.EachfractionwasanalyzedbyimmunoblottingusingtheHA,FLAGandMyc
mAbs for detection of HA-GCMa, CBP-Flag and HDAC3-Myc, respectively.
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proteins. As shown in Figure 4A, GST-HDAC3, but not GST,
directly and speciﬁcally interacted with GCMa-Flag and
Flag-CBP, respectively. We further mapped the interaction
domains of GCMa and CBP binding HDAC3. For CBP
domain mapping, a series of GST–CBP fusion proteins
were incubated with MBP or MBP-HDAC3 for GST pull-
down analysis. Speciﬁc interactions were detected between
HDAC3 and the regions of amino acids 1–451 and
1892–2163 in CBP (Figure 4B, left panel). No interaction
was detected when only MBP was incubated with
GST–CBP fusion proteins (Figure 4B, left panel). A similar
experiment was performed for GCMa domain mapping by
incubating a series of GST–GCMa fusion proteins with
MBP or MBP-HDAC3. As shown in Figure 4B (right
panel), speciﬁc interactions were detected between HDAC3
Figure 4. MappingoftheHDAC3-interactingdomainsofGCMaandCBP.(A)HDAC3directlyinteractswithGCMaandCBP.Analiquotof0.4mgofrecombinant
GCMa-FlagorFlag-CBPproteinwereincubatedwith2.5mgofrecombinantGSTorGST-HDAC3proteinforGSTpull-downanalysisasdescribedinMaterialsand
Methods. Coomassie brilliant blue 250 staining of recombinant proteins is presented. (B) Mapping of the interacting domains of GCMa and CBP for HDAC3. An
aliquot of 0.4 mg of MBP or MBP-HDAC3 protein was incubated with 2.5 mg of GST or the indicated GST fusion protein containing truncated CBP domain (as
indicatedbythenumberunderneathGST-CBP)forGSTpull-downanalysis.Similarly,0.6mgofMBPorMBP-HDAC3proteinwasincubatedwith2.5mgofGSTor
theindicatedGSTfusionproteincontainingtruncatedGCMadomain(asindicatedbythenumberunderneathGST-GCMa)forGSTpull-downanalysis.Coomassie
brilliant blue 250 staining of GST, GST-CBP truncated proteins, and GST-GCMa full-length and truncated proteins are presented.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1465and the regions of amino acids 167–349 and 300–436 in
GCMa,suggestingthatbothregions areinvolved ininteraction
with HDAC3.
HDAC3 represses CBP transcriptional coactivator
activity and CBP-enhanced GCMa transcriptional
activity
Since CBP can be self-acetylated via its own HAT activity and
can interact with HDAC3 as described above, we tested
whether HDAC3 can deacetylate CBP. 293T cells were trans-
fected with pCBP-HA alone or together with pHDAC3-Myc,
followed by acetylation assays using HA mAb for immuno-
precipitation and Ac-K mAb for immunoblotting. As shown in
Figure 5A, acetylation of CBP was detected, which could be
inhibited in the presence of HDAC3. We also tested the effect
of HDAC3 on CBP activity in terms of transcriptional
coactivation. JEG3 cells were cotransfected with pG5E1bLUC
and pGal4-CBP-Flag alone or pGal4-CBP-Flag plus
increasing amounts of pHDAC3-Flag. The luciferase activity
directed by pG5E1bLUC was stimulated by Gal4-CBP-Flag
(Figure 5B). However, this activation was signiﬁcantly
counteracted when increasing amounts of HDAC3-Flag was
coexpressed (Figure 5B). On the other hand, cotransfection
with pHDAC4-Flag only mildly repressed the CBP activity
considering the relatively higher level of HDAC4-Flag protein
in the transfected cells (Figure 5B). Taken together, these
results suggested that HDAC3 can deacetylate CBP and
Figure 5. HDAC3 regulates CBP and GCMa activities. (A) HDAC3 deacetylates CBP in vivo. 293T cells were transfected with pCBP-HA alone or together with
pHDAC3-Myc. After 48 h post-transfection, cells were harvested for analysis of acetylated CBP-HA by immunoprecipitation and immunoblotting using HA and
Ac-K mAbs, respectively. (B) HDAC3 has a stronger inhibitory effect than HDAC4 on the transcriptional coactivator activity of CBP. JEG3 cells were transfected
with the indicated combinations of 0.1 mg of pG5LUC, 0.01 mg of pGal4CBP-Flag and increasing amounts of pHDAC3-Flag (0.4 and 0.8 mg) or pHDAC4-Flag
(0.025and0.05mg).After48hpost-transfection,cellswereharvestedforluciferaseassayasdescribedinMaterialsandMethods.MeanvaluesandtheSEMobtained
from six independent transfection experiments are presented. The protein levels of HDAC3- and 4-Flag and b-actin in the WCL are presented. (C) HDAC3 and
4 repress the enhancement effect of CBP on GCMa-mediated transcriptional activation. 293T cells were transfected with the indicated combinations of 0.2 mgo f
p(pGBS)4E1bLUC,0.17mgofpHA-GCMa,0.17mgofpCBP-HA,0.17mgofpCBP
HAT-HA,0.17mgofpHDAC3-Flagand0.026mgofpHDAC4-Flag.Meanvalues
and the SEM obtained from six independent transfection experiments are presented. (D) Stabilization of GCMa by CBP was counteracted by HDAC3. 293T cells
weretransfectedwithdifferentcombinationsof1.5mgofpHA-GCMa,0.75mgofpCBP-Flagand1.25mgofpHDAC3-Flag.After36hpost-transfection,cellswere
pulsedwith[
35S]-methioninefor1handthenchasedwithcoldmethioninefortheindicatedtime.RadioactiveHA-GCMaproteinswereimmunoprecipitatedbyHA
mAb,analyzedbySDS–PAGEandfluorography,andquantifiedbyabioimaginganalyzer.MeanvaluesandtheSEMfromtwoindependenttransfectionexperiments
are presented.
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We next tested whether HDAC3 and 4 also regulates CBP-
enhanced GCMa transcriptional activity. To this end, 293T
cells were transfected with different combinations of
p(GBS)4E1bLUC, pHA-GCMa, pCBP-HA and pHDAC3-
and 4-Flag. As shown in Figure 5C, the luciferase activity
directed by p(GBS)4E1bLUC was activated by GCMa.
Moreover, HDAC3 and 4 did not signiﬁcantly affect the
observed GCMa-mediated transcriptional activation, whereas
CBP signiﬁcantly enhanced it. However, the enhancement
effect of CBP on GCMa transcriptional activity was repressed
in the presence of HDAC3 or 4 (Figure 5C) when a similar
level of HDAC3- or 4-Flag protein was expressed in the
transfected cells (data not shown). We were curious about
whether HDAC3 counteracts the HAT activity of CBP and
imposed the observed repression effect. To this end, a HAT
mutant CBP expression plasmid, pCBP
HAT-HA, was tested
in transient expression experiments. As shown in Figure 5C,
consistent with our previous study (12), the enhancement
effect of CBP
HAT on GCMa transcriptional activity was
lower than that of wild-type CBP. Moreover, HDAC3 and
4 did not signiﬁcantly repress the enhancement effect of
CBP
HAT (Figure 5C), suggesting that HDAC3 and 4 prim-
arily counteracts the HAT activity of CBP thereby repressing
the CBP-enhanced GCMa transcriptional activation. On the
other hand, since acetylation of GCMa by CBP increases the
stability of GCMa, we examined whether HDAC3 can reverse
the stabilizing effect of CBP on GCMa by comparing the half-
lives of GCMa in 293T cells transfected with different com-
binations of pHA-GCMa, pCBP-Flag and pHDAC3-Flag.
As shownin Figure 5D,the half-life of GCMa was notaffected
by HDAC3, but was signiﬁcantly prolonged in the presence
of CBP. However, the stabilizing effect of CBP on GCMa
was repressed when GCMa was coexpressed with CBP
and HDAC3 (Figure 5D). Therefore, HDAC3 can reverse
the stabilizing effect of CBP on GCMa, which is very likely
attributed to the above-mentioned repression effect of HDAC3
on the CBP-enhanced GCMa transcriptional activation.
Regulation of GCMa activity by HDAC3 in
placental cells
Because sycnytin gene is a direct target gene of GCMa,
we now investigated if HDAC3 has any role in the regulation
of sycnytin gene expression. To determine the association
of HDAC3 with the syncytin promoter, ChIP assays were
performed to analyze the association of HDAC3 with the
proximal GCMa-binding site (pGBS) in the syncytin promoter
in mock-, forskolin- and TSA-treated BeWo cells. As shown
in Figure 6A, association of HDAC3 with pGBS was detected
in mock- or TSA-treated BeWo cells. Interestingly, the asso-
ciation of HDAC3 with pGBS was signiﬁcantly decreased
when BeWo cells were treated with forskolin. As a control,
HDAC3 did not associate with a designated promoter region
of GADPH (Figure 6A). On the other hand, acetylation of
histone 3 (Ac-H3) around the pGBS site was detected and
not signiﬁcantly changed in all three groups of BeWo cells
(Figure 6A). Therefore, the association of HDAC3 with the
syncytin promoter is dynamic and is decreased by forskolin, a
stimulatory factor for syncytin gene expression.
We further investigated the role of HDAC3 and 4 in the
regulation of sycnytin gene expression by transient expression
experiments. To this end, we ﬁrst tested the effect of TSA on
syncytin promoter activity by transfecting placental JAR cells
with pLUC(25468–30953), followed by treatment without or
Figure 6. RegulationofsyncytingeneexpressionbyHDAC3and4.(A)HDAC3associateswiththepGBSinthesyncytinpromoter.BeWocellsweremock-treated
or treatedwith 50 mM forskolinfor24 h or50 ng/mlof TSA for12 h andanalyzed by ChIPassays fora promoter regioncoveringpGBS in the syncytingeneor fora
promoter region in the GAPDH gene. A reaction was performed in the absence of antibody as a control (no Ab). Serial dilutions of input chromatin DNA were
analyzed in PCR with primers for the syncytin promoter. (B) TSA stimulates syncytin promoter activity and HDAC3 and 4 repress the syncytin promoter activity
activatedbyGCMaandCBP.JARcellsweretransfectedwiththeindicatedcombinationsof0.1mgofpLUC(25468–30953),0.1mgofpHA-GCMa,0.1mgofpCBP-
HAand0.2mgofpHDAC3-and4-Flag.After24hpost-transfection,cellsweremock-treatedortreatedwithincreasingamountsofTSAforanother24h.Meanvalues
and the SEM obtained from three independent transfection experiments are presented.
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transcriptional activity directed by pLUC(25468–30953) was
stimulated byTSAat15or25ng/ml,suggestingthatinhibition
of HDAC activity can upregulate syncytin promoter activity.
Since it is known that syncytin promoter activity is upregu-
lated by GCMa and CBP (12), we also tested whether HDAC3
and 4 could affect GCMa and CBP-upregulated syncytin
promoter activity by transfecting JAR cells with different
combinations of pLUC(25468–30953), pCBP-HA, pHA-
GCMa and pHDAC3- and 4-Flag. Consistent with our recent
ﬁndings, GCMa and CBP stimulated the reporter activity
directed by pLUC(25468–30953) via the syncytin promoter
element (Figure 6B). However, the observed transcriptional
activation of syncytin promoter was repressed in the presence
of HDAC3 or 4 (Figure 6B). Taken together, these results
suggested that HDAC3 and 4 represses the syncytin promoter
activity activated by CBP and GCMa.
DISCUSSION
Human placental villi are covered with a terminally differen-
tiated multinucleated syncytiotrophoblast layer, which is
responsible for most of the transport and endocrine activities
of placenta during pregnancy. Syncytin can mediate tropho-
blastic fusion and is therefore an important effector in the
formation of syncytiotrophoblast layer. GCMa regulates syn-
cytin gene expression, which can be further stimulated by the
cAMP/PKA signaling pathway with CBP, a transcription
coactivator and a HAT, that acetylates GCMa and thereby
prolongs the half-life of GCMa. In the present study, we
provided evidence that HDAC3 is a key factor that negatively
regulates GCMa activity via deacetylation of GCMa. Several
lines of evidence support this conclusion. First, the HDAC
inhibitor, TSA, elevated the level of acetylated GCMa, sug-
gestive of a functional interaction between HDAC and GCMa.
Second, HDAC3 physically interacted with and deacetylated
GCMa. Third, the enhancement effect of CBP on GCMa-
mediated transcriptional activation was counteracted by
HDAC3.
Protein acetylation regulates a variety of protein functions
involved in chromatin assembly, protein–protein interaction,
stability, DNA-binding activity, transcriptional activity and
nuclear localization. Interestingly, a target protein may inter-
act with several HDACs. For example, Stat3 can interact with
HDAC1, 2 and 3, and RUNX3 can interact with HDAC1, 2, 4
and 5 (19,20). In addition to HDAC3, we also demonstrated
that GCMa co-immunoprecipitates with and is deactylated by
HDAC1, 4 and 5 in the current study. By searching expressed
sequence tag (EST) expression proﬁles in GenBank, we found
that HDAC1, 3, 4 and 5 transcripts are expressed in human
placenta, suggesting that HDAC1, 3, 4 and 5 are all likely to
play a role in the deacetylation of GCMa in placenta. HDAC4
and 5, two class II HDACs, are able to shuttle in and out of the
nucleus in response to certain cellular signals as in the case of
muscle differentiation in which phosphorylation of HDAC4
and 5 by Ca
2+/calmodulin-dependent kinase causes both
HDACs to relocalize from the nucleus to the cytoplasm
(21). It will be interesting to investigate whether shuttling
of HDAC4 and 5 takes place in placenta and regulates
GCMa activity.
It is generally believed that the syncytiotrophoblast layer
undergoes apoptosis and is replenished by cell–cell fusion of
subjacent mononucleated cytotrophoblasts. Therefore, a
balance between apoptosis and cell–cell fusion is imperative
to maintain the syncytiotrophoblast layer as a steady-state
structure in placenta during pregnancy. Apparently GCMa
plays a pivotal role in this balancing mechanism because
GCMa regulates syncytin gene expression and consequently
trophoblastic fusion. Once GCMa activity is increased as
induced by cAMP/PKA signaling, it is thought that the
dynamics of the syncytiotrophoblast layer will be tilted toward
trophoblastic fusion. Should GCMa activity be too high, the
steady-state structure of the syncytiotrophoblast layer may be
affected in such a way as to cause adverse effects on placental
functions. Therefore, a counteracting mechanism to reduce
GCMa activity is critical to maintaining normal placental
functions. In the present study, we found that HDAC3
associates with pGBS in the syncytin promoter in placental
BeWo cells and turns into a dissociated form in the presence of
forskolin. In accordance with our previous ChIP studies, that
forskolin enhances the association of GCMa and CBP with
pGBS, it is a feasible to speculate that CBP displaces HDAC3
from GCMa on pGBS when syncytin gene expression is
stimulated by forskolin. The displacement of HDAC3
from GCMa by CBP may involve a direct interaction between
CBP and HDAC3 as supported by GST pull-down and
sedimentation analyses. On the other hand, when the level
of GCMa (most likely in the acetylated form as in the presence
of TSA) on pGBS is increased, HDAC3 associates with
GCMa (Figure 6A), very likely for the reason of deacetylating
GCMa and hence reducing the GCMa activity as ubiqutination
of deacetylated GCMa can take place subsequently.
Correlatively, we also demonstrated that HDAC3 reduces
syncytin promoter activity activated by CBP and GCMa in
transient expression experiments (Figure 6B). Together with
our previous ﬁndings that CBP HAT upregulates GCMa
activity, this study supports that HDAC3 plays an important
role in counteracting elevated GCMa activity. Therefore,
trophoblstic fusion in normal placental morphogenesis may
heavily rely on the regulation of GCMa activity by HAT and
HDAC.
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